SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001493152-24-016951
Filing Date
2024-04-29
Accepted
2024-04-29 16:05:15
Documents
12
Period of Report
2024-04-29

Document Format Files

Seq Description Document Type Size
1 formdef14a.htm DEF 14A 897936
2 formdef14a_001.jpg GRAPHIC 5112
3 formdef14a_002.jpg GRAPHIC 18112
4 formdef14a_003.jpg GRAPHIC 19351
5 proxy_001.jpg GRAPHIC 227594
6 proxy_002.jpg GRAPHIC 159428
7 proxy_003.jpg GRAPHIC 226744
8 proxy_004.jpg GRAPHIC 159439
9 proxy_005.jpg GRAPHIC 226230
10 proxy_006.jpg GRAPHIC 159428
11 proxy_007.jpg GRAPHIC 226200
12 proxy_008.jpg GRAPHIC 159385
  Complete submission text file 0001493152-24-016951.txt   3086433
Mailing Address 160 SECOND STREET CAMBRIDGE CAMBRIDGE MA 02142
Business Address 160 SECOND STREET CAMBRIDGE CAMBRIDGE MA 02142 617-830-3031
VBI Vaccines Inc/BC (Filer) CIK: 0000764195 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37769 | Film No.: 24890577
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)